Gladstone Institutes

03/20/2026

Happiness is a shared discovery.

This International Day of Happiness, we’re celebrating one of our core values: Enjoy the Journey.

At Gladstone, that means finding joy in the everyday moments—bringing curiosity and playfulness into our work, celebrating the incredible people around us, and staying engaged in a community where every contribution matters.

From the lab to our shared spaces, it’s the smiles, connections, and sense of purpose that make the journey just as meaningful as the destination.

What’s bringing you happiness today? 🧡

03/19/2026

isn’t just accelerating discovery at Gladstone, it’s changing the very questions we can ask.

In this video, Postdoc Shijie Wang shares how deep learning and robotic microscopy help our teams spot the earliest signs of neurodegeneration, track thousands of living cells, and uncover patterns humans might miss. With these tools, we can explore bigger ideas, move faster, and push science into new territory.

03/18/2026

Designing vaccines for the world’s toughest diseases isn’t easy—but it’s exactly what drives Kim Dam.

At Gladstone, she’s helping engineer a next-generation vaccine platform aimed at tackling HIV, influenza, malaria, and more.

From Wisconsin to Gladstone, Kim Dam is helping engineer a next-generation vaccine platform designed to tackle some of the world’s most challenging infectious diseases.

03/18/2026

Deepak Srivastava offers perspective on the emerging use of mesenchymal stem-cells and the questions that remain about their therapeutic value.

A San Francisco startup is paying women $40 to drop off their period blood in a downtown coworking space bathroom.

03/17/2026

Happy St. Patrick’s Day 🍀

We’re celebrating with a little green—through the lens of science.
These microscopy images highlight the hidden beauty inside cells, where even the smallest details can lead to big discoveries.

Because sometimes, finding a cure starts with seeing things a little differently.

03/17/2026

Gladstone President Deepak Srivastava explains how Gladstone's model tightly integrates experts with biomedical researchers to create powerful tools designed to solve some of the most challenging and currently untreatable diseases.

By combining cutting-edge AI with deep knowledge of disease biology, Gladstone is accelerating discoveries and moving closer to something once thought impossible: real cures.

03/17/2026

From chronic treatment to true cure: Melanie Ott makes the case that controlling HIV isn’t the finish line—it’s just the beginning.

Read the full story on our website. Link in comments.

03/16/2026

Brain Awareness Week is a reminder of just how much we still have to learn about the brain—and why understanding disease at its roots matters.

At Gladstone Institutes, scientists are uncovering the biological mechanisms behind neurological conditions like Alzheimer’s disease, Parkinson’s disease, stroke, and traumatic brain injury—and turning those discoveries into potential treatments.

From stem cell therapies that may help the brain recover after stroke to machine-learning tools that detect early signs of Alzheimer’s, researchers are exploring new ways to diagnose, prevent, and treat devastating brain disorders.

For World Brain Day, discover some of Gladstone’s latest breakthroughs in neurological research.

03/15/2026

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and transmission.

Scientists have developed a novel tool-named HIV-seq-for profiling the features of rare HIV-infected cells from people with HIV. Using the new tool, they've found key differences in people's HIV-infected cells before versus after starting antiretroviral therapy.

03/14/2026

A team at Gladstone developed a new framework that matches vitamins with genetic diseases. This strategy helped uncover that high-dose vitamin B3 can dramatically extend survival in mice with NAXD deficiency.

03/14/2026

Researchers at Gladstone have developed a novel method to profile rare -infected cells in people on antiretroviral therapy.

Researchers at the Gladstone Institutes and San Francisco VA Medical Center have developed a new tool called HIV-seq that can profile the features of rare HIV-infected cells from people with HIV on antiretroviral therapy. The tool allows scientists to better understand how HIV-infected cells persist...

03/13/2026

Every human genome contains 3 billion base pairs.

Today, sequencing a genome only costs about $300, which means scientists could now have access to genetic data from millions of people. But within that massive amount of information, only a small number of genetic changes actually help explain disease.

So how do researchers find the meaningful signals in a sea of data?

At Gladstone, scientists rely on AI. Data scientists build powerful models that predict which genetic changes may cause disease, and biologists test those predictions in the lab—turning data into real biological insight and, ultimately, potential therapies.

Discover how researchers are using AI to decode the complexity of human biology on our website.